Robert Coleman
Robert Coleman
Verified email at
Cited by
Cited by
Alpha emitter radium-223 and survival in metastatic prostate cancer
C Parker, S Nilsson, D Heinrich, SI Helle, JM O'Sullivan, SD Fosså, ...
New England Journal of Medicine 369 (3), 213-223, 2013
Clinical features of metastatic bone disease and risk of skeletal morbidity
RE Coleman
Clinical cancer research 12 (20), 6243s-6249s, 2006
Metastatic bone disease: clinical features, pathophysiology and treatment strategies
RE Coleman
Cancer treatment reviews 27 (3), 165-176, 2001
Skeletal complications of malignancy
RE Coleman
Cancer: Interdisciplinary International Journal of the American Cancer …, 1997
2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial
I Smith, M Procter, RD Gelber, S Guillaume, A Feyereislova, M Dowsett, ...
The lancet 369 (9555), 29-36, 2007
Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women …
DLW Kwong, P McGale, C Taylor, C Correa, D Cutter, F Duane, M Ewertz, ...
The Lancet, 2014
The clinical course of bone metastases from breast cancer
RE Coleman, RD Rubens
British journal of cancer 55 (1), 61-66, 1987
Adjuvant docetaxel for node-positive breast cancer
M Martin, T Pienkowski, J Mackey, M Pawlicki, JP Guastalla, C Weaver, ...
New England Journal of Medicine 352 (22), 2302-2313, 2005
Zoledronic acid versus pamidronate in the treatment of skeletal metastases in patients with breast cancer or osteolytic lesions of multiple myeloma: a phase III, double-blind …
LS Rosen, D Gordon, M Kaminski, A Howell, A Belch, J Mackey, ...
Cancer journal (Sudbury, Mass.) 7 (5), 377-387, 2001
Long‐term efficacy and safety of zoledronic acid compared with pamidronate disodium in the treatment of skeletal complications in patients with advanced multiple myeloma or …
LS Rosen, D Gordon, M Kaminski, A Howell, A Belch, J Mackey, ...
Cancer: Interdisciplinary International Journal of the American Cancer …, 2003
Survival and safety of exemestane versus tamoxifen after 2–3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial
RC Coombes, LS Kilburn, CF Snowdon, R Paridaens, RE Coleman, ...
The Lancet 369 (9561), 559-570, 2007
Denosumab and bone-metastasis-free survival in men with castration-resistant prostate cancer: results of a phase 3, randomised, placebo-controlled trial
MR Smith, F Saad, R Coleman, N Shore, K Fizazi, B Tombal, K Miller, ...
The Lancet 379 (9810), 39-46, 2012
Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials
B Asselain, W Barlow, J Bartlett, J Bergh, E Bergsten-Nordström, J Bliss, ...
The Lancet Oncology 19 (1), 27-39, 2018
Adjuvant ovarian suppression in premenopausal breast cancer
PA Francis, MM Regan, GF Fleming, I Láng, E Ciruelos, M Bellet, ...
New England Journal of Medicine 372 (5), 436-446, 2015
Topotecan versus paclitaxel for the treatment of recurrent epithelial ovarian cancer.
W ten Bokkel Huinink, M Gore, J Carmichael, A Gordon, J Malfetano, ...
Journal of Clinical Oncology 15 (6), 2183-2193, 1997
Phase III randomized trial of docetaxel–carboplatin versus paclitaxel–carboplatin as first-line chemotherapy for ovarian carcinoma
PA Vasey, GC Jayson, A Gordon, H Gabra, R Coleman, R Atkinson, ...
Journal of the National Cancer Institute 96 (22), 1682-1691, 2004
Pathologic fractures correlate with reduced survival in patients with malignant bone disease
F Saad, A Lipton, R Cook, YM Chen, M Smith, R Coleman
Cancer 110 (8), 1860-1867, 2007
Zoledronic acid reduces skeletal‐related events in patients with osteolytic metastases: A double‐blind, randomized dose–response study
JR Berenson, LS Rosen, A Howell, L Porter, RE Coleman, W Morley, ...
Cancer 91 (7), 1191-1200, 2001
Bone turnover markers as predictors of skeletal complications in prostate cancer, lung cancer, and other solid tumors
JE Brown, RJ Cook, P Major, A Lipton, F Saad, M Smith, KA Lee, M Zheng, ...
Journal of the National Cancer Institute 97 (1), 59-69, 2005
Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials
Early Breast Cancer Trialists' Collaborative Group
The Lancet 386 (10001), 1353-1361, 2015
The system can't perform the operation now. Try again later.
Articles 1–20